We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.6%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$8.89B
AUM Growth
+$1.45B
Cap. Flow
+$1.09B
Cap. Flow %
12.29%
Top 10 Hldgs %
26.12%
Holding
266
New
39
Increased
114
Reduced
52
Closed
27

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$63.8M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$50M
3
VR
Validus Hold Ltd
VR
+$44.1M
4
PBYI icon
Puma Biotechnology
PBYI
+$33.5M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$30.4M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$59.3M
2
DHR icon
Danaher
DHR
+$44.2M
3
HOLX
Hologic
HOLX
+$42M
4
BDX icon
Becton Dickinson
BDX
+$40.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$38.7M

Sector Composition

Rank Sector Weight
1 Financials 21.97%
2 Healthcare 21.33%
3 Technology 19.13%
4 Communication Services 9.13%
5 Industrials 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRO icon
151
Brown & Brown
BRO
$22.9B
$12.4M 0.14%
513,900
+62,000
+14% +$1.39M
MU icon
152
Micron Technology
MU
$1.04T
$12.1M 0.14%
+308,166
New +$9.74M
RL icon
153
Ralph Lauren
RL
$22.2B
$12.1M 0.14%
137,229
– –
LH icon
154
Labcorp
LH
$24.3B
$11.9M 0.13%
92,072
-23,783
-21% -$3.17M
CNC icon
155
Centene
CNC
$31.3B
$11.6M 0.13%
240,000
-5,082
-2% -$219K
PAYC icon
156
Paycom
PAYC
$6.78B
$11.1M 0.12%
147,910
– –
TSRO
157
DELISTED
TESARO, Inc.
TSRO
$10.3M 0.12%
80,000
+30,000
+60% +$3.72M
AUPH icon
158
Aurinia Pharmaceuticals
AUPH
$1.97B
$10.1M 0.11%
1,618,352
+435,080
+37% +$2.74M
ARCC icon
159
Ares Capital
ARCC
$13.5B
$10.1M 0.11%
616,732
+129,232
+27% +$2.09M
FWONK icon
160
Liberty Media Series C
FWONK
$24.3B
$10.1M 0.11%
+274,854
New +$9.61M
EBAY icon
161
eBay
EBAY
$48.6B
$10M 0.11%
260,493
– –
NGD
162
DELISTED
New Gold Inc
NGD
$9.86M 0.11%
+2,654,392
New +$9.17M
WOLF icon
163
Wolfspeed
WOLF
$1.2B
$9.79M 0.11%
+347,409
New +$8.64M
RVTY icon
164
Revvity
RVTY
$12.3B
$9.79M 0.11%
141,887
-398,732
-74% -$26.7M
BX icon
165
Blackstone
BX
$104B
$9.75M 0.11%
292,221
+42,228
+17% +$1.39M
MA icon
166
Mastercard
MA
$477B
$9.4M 0.11%
66,556
+3,183
+5% +$421K
SLRC icon
167
SLR Investment Corp
SLRC
$706M
$9.22M 0.1%
426,278
+48,778
+13% +$1.05M
SIVB
168
DELISTED
SVB Financial Group
SIVB
$8.95M 0.1%
47,856
+14,132
+42% +$2.49M
BSX icon
169
Boston Scientific
BSX
$65.8B
$8.87M 0.1%
304,266
– –
KEY icon
170
KeyCorp
KEY
$24.3B
$8.11M 0.09%
430,834
+66,303
+18% +$1.2M
LFUS icon
171
Littelfuse
LFUS
$10.2B
$8.07M 0.09%
41,194
+4,229
+11% +$768K
PFLT icon
172
PennantPark Floating Rate Capital
PFLT
$681M
$8.04M 0.09%
555,750
+95,750
+21% +$1.36M
BKNG icon
173
Booking.com
BKNG
$138B
$8.03M 0.09%
109,675
-42,550
-28% -$3.23M
REGN icon
174
Regeneron Pharmaceuticals
REGN
$68.8B
$7.83M 0.09%
17,500
-81,263
-82% -$38.7M
TTWO icon
175
Take-Two Interactive
TTWO
$43B
$7.78M 0.09%
76,093
-21,650
-22% -$1.94M
5 6
7
8 9

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Polar Capital held 266 positions worth $8.89B, up 20% from $7.43B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Polar Capital deployed $1.09B of net new capital in Q3 2017, opening 39 new positions and adding to 114 existing holdings. Its largest new stake was Puma Biotechnology: 360,000 shares worth $43.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Medtronic, an estimated $59.3M trimmed.

  • Polar Capital's largest Q3 2017 buy was Puma Biotechnology: 360,000 shares worth $43.1M.
  • Polar Capital added most to Amgen in Q3 2017, an estimated $63.8M increase.
  • Polar Capital's biggest Q3 2017 reduction was Medtronic, cutting an estimated $59.3M.
  • Polar Capital fully exited Hologic in Q3 2017, selling an estimated $42M.
  • Polar Capital's ten largest holdings make up 26% of its $8.89B portfolio in Q3 2017.
  • Polar Capital opened 39 new positions and closed 27 in Q3 2017.
  • Polar Capital's portfolio value rose 20% quarter-over-quarter to $8.89B.

Based on Polar Capital's 13F filing for Q3 2017, filed 14 Nov 2017.